Certara Inc

CERT is in a Stage 2 advancing phase with a medium-term bullish bias underscored by a confirmed Momentum Breakout and rising EMAs. Price is currently pulling back into the rising 9 EMA and 20 EMA without signs of exhaustion, offering favorable execution timing. The long-term trend remains bearish, anchored by a declining 200 DMA. Buy now to engage continuation participation on shallow pullbacks into EMAs.

• ↑Software revenue rose 7% YoY to $49.7M in Q1 2026, driving top-line growth.
• ↑AI integration and FDA’s animal-testing phase-out create regulatory tailwinds.
• ↓Service revenue fell 4% in Q1 2026, reflecting Tier 1 client caution.